Jaundice during pregnancy can be caused by various factors, including physiological changes, pregnancy-related liver disorders, viral infections, and other medical conditions.
Get the full solved assignment PDF of MME-302/As-4 of 2024 session now.
Managing a pregnant woman who tests positive for Hepatitis B surface antigen (HBsAg) involves comprehensive evaluation, monitoring, and implementation of appropriate interventions to ensure optimal maternal and fetal outcomes while minimizing the risk of vertical transmission of the virus. Here’s a discussion on the causes of jaundice during pregnancy and the management of a pregnant woman with positive HBsAg:
Causes of Jaundice During Pregnancy:
- Physiological Changes:
- Pregnancy-induced hormonal and metabolic changes can affect liver function, leading to mild elevations in bilirubin levels and transient jaundice in some women, especially during the third trimester.
- Pregnancy-Related Liver Disorders:
- Intrahepatic cholestasis of pregnancy (ICP), also known as obstetric cholestasis, is a liver disorder characterized by impaired bile flow, pruritus (itching), and elevated serum bile acid levels, leading to jaundice and increased risk of adverse pregnancy outcomes, such as preterm birth and fetal distress.
- Viral Hepatitis:
- Hepatitis viruses, including Hepatitis A, B, and E viruses, can cause acute viral hepatitis during pregnancy, resulting in jaundice, hepatomegaly (enlarged liver), elevated liver enzymes, and potential complications for both the mother and fetus.
- Chronic Liver Disease:
- Pre-existing liver diseases, such as chronic viral hepatitis (e.g., Hepatitis B, Hepatitis C), autoimmune hepatitis, alcoholic liver disease, or non-alcoholic fatty liver disease (NAFLD), may worsen or become symptomatic during pregnancy, leading to jaundice and liver dysfunction.
- Gestational Hyperbilirubinemia:
- Physiological hyperbilirubinemia due to increased red blood cell turnover, hemolysis, or reduced hepatic conjugation of bilirubin can occur during pregnancy, leading to mild jaundice without significant liver injury or pathology.
Management of a Pregnant Woman Tested Positive for HBsAg:
- Confirmation of Diagnosis:
- Confirm the diagnosis of chronic Hepatitis B infection by repeat testing for HBsAg, Hepatitis B surface antibody (anti-HBs), Hepatitis B e antigen (HBeAg), Hepatitis B core antibody (anti-HBc), and quantitative HBV DNA viral load.
- Antenatal Care and Monitoring:
- Provide comprehensive antenatal care, including regular prenatal visits, obstetric ultrasound, and laboratory tests, to monitor maternal and fetal health status, assess for complications, and optimize pregnancy outcomes.
- Monitor liver function tests, including serum bilirubin, transaminases (AST, ALT), alkaline phosphatase (ALP), and serum albumin levels, to assess liver function and detect signs of liver injury or dysfunction.
- Prevention of Vertical Transmission:
- Administer passive-active immunoprophylaxis to the newborn immediately after birth, including Hepatitis B vaccine and Hepatitis B immunoglobulin (HBIG), to prevent vertical transmission of Hepatitis B virus (HBV) from mother to infant.
- Encourage breastfeeding for infants born to HBsAg-positive mothers, as the benefits of breastfeeding outweigh the low risk of HBV transmission, especially when infants receive appropriate immunoprophylaxis.
- Management of Liver Disease:
- Refer the patient to a hepatologist or gastroenterologist for specialized evaluation and management of chronic Hepatitis B infection, including assessment of liver fibrosis, staging of liver disease, and consideration of antiviral therapy (e.g., oral nucleos(t)ide analogues) to suppress viral replication and reduce the risk of liver-related complications.
- Monitor maternal liver function and viral load throughout pregnancy, adjusting antiviral therapy as needed to maintain viral suppression and prevent disease progression.
- Patient Education and Counseling:
- Provide counseling and education to the patient regarding the natural history of chronic Hepatitis B infection, modes of transmission, methods of prevention, importance of adherence to antenatal care and immunoprophylaxis protocols, and implications for maternal and fetal health.
- Coordination of Care:
- Collaborate with obstetricians, midwives, infectious disease specialists, and pediatricians to ensure coordinated care, communication, and follow-up for the pregnant woman and her infant, addressing maternal and neonatal health needs throughout the perinatal period.
- Postpartum Follow-Up:
- Schedule postpartum follow-up visits for the mother and infant to assess maternal and neonatal health status, monitor for signs of liver disease exacerbation or neonatal HBV infection, and provide ongoing medical care and support as needed.
By implementing a multidisciplinary approach to the management of pregnant women with positive HBsAg, healthcare providers can optimize maternal and fetal outcomes, reduce the risk of vertical transmission of HBV, and promote the health and well-being of both mother and child. Early diagnosis, comprehensive antenatal care, and adherence to evidence-based management guidelines are essential components of effective care for pregnant women with chronic Hepatitis B infection.